Free Trial

Reckitt Benckiser Group (LON:RKT) Trading 2.2% Higher - Here's What Happened

Reckitt Benckiser Group logo with Consumer Defensive background

Reckitt Benckiser Group plc (LON:RKT - Get Free Report) shot up 2.2% during mid-day trading on Friday . The stock traded as high as GBX 4,868 ($61.03) and last traded at GBX 4,847 ($60.76). 1,886,302 shares traded hands during mid-day trading, a decline of 41% from the average session volume of 3,203,260 shares. The stock had previously closed at GBX 4,741 ($59.43).

Wall Street Analyst Weigh In

Several brokerages have commented on RKT. Berenberg Bank cut their price target on shares of Reckitt Benckiser Group from GBX 5,200 ($65.19) to GBX 5,177 ($64.90) and set a "hold" rating for the company in a report on Wednesday, October 23rd. JPMorgan Chase & Co. cut Reckitt Benckiser Group to a "neutral" rating in a research report on Friday, August 30th. Finally, Jefferies Financial Group reaffirmed a "hold" rating and issued a GBX 4,400 ($55.16) price target on shares of Reckitt Benckiser Group in a report on Monday, July 29th.

Get Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Price Performance

The company has a market capitalization of £33.50 billion, a PE ratio of 2,233.64, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 112.52. The firm's 50-day moving average is GBX 4,714.96 and its 200-day moving average is GBX 4,495.09.

Insider Transactions at Reckitt Benckiser Group

In other Reckitt Benckiser Group news, insider Fiona Dawson purchased 25 shares of the firm's stock in a transaction on Wednesday, October 23rd. The shares were purchased at an average cost of GBX 4,923 ($61.71) per share, with a total value of £1,230.75 ($1,542.87). Company insiders own 0.05% of the company's stock.

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Featured Articles

→ Let’s be blunt (From DTI) (Ad)

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines